Drawing for EGIRIO

USPTO serial 78181702

EGIRIO

Reviewed by CopyMark Law Group

Status 605
Filing date
Status date
Registration date
—
Examiner
SHARPER JR, SAM
Law office
INTENT TO USE SECTION

What this means

This page summarizes the public USPTO record for this serial number, including owners, goods and services, and prosecution history.

Need help with EGIRIO?

If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.

Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.

Owner

Attorney of record

The USPTO lists this attorney as the applicant's representative for correspondence on this application.

Stacey Hallerman

STACEY HALLERMAN C/O PRIZER INC150 E 42ND STNEW YORK, NY 10017UNITED STATES

Goods and services

ClassDescriptionStatusFirst use
005Pharmaceutical preparations for the treatment of cardiovascular disease, central nervous system diseases and disorders, neurological disorders, urological disorders, urogenital disorders, gastrointestinal disorders, musculoskeletal disorders, allergies, diabetes, hypertension, erectile dysfunction, sexual dysfunction, stroke, cancer, migraines, pain, obesity, inflammation, inflammatory diseases, respiratory diseases, infectious diseases, immunological disorders, viral disorders, fungal disorders; pharmaceutical preparations, namely, cholesterol preparations, smoking cessation preparations, dermatological preparations, gynecological preparations, osteoporosis preparations, opthalmological preparationsABANDONED—

Related trademarks

CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.

Prosecution history

DateCodeEventWhat it means
Jul 1, 2005ABN5ABANDONMENT - AFTER PUBLICATION—
Jul 1, 2005EXARTEAS EXPRESS ABANDONMENT RECEIVED—
Jun 1, 2005DOCKASSIGNED TO EXAMINER—
May 31, 2005DOCKASSIGNED TO EXAMINER—
Mar 21, 2005DOCKASSIGNED TO EXAMINER—
Mar 8, 2005DOCKASSIGNED TO EXAMINER—
Mar 7, 2005DOCKASSIGNED TO EXAMINER—
Feb 15, 2005EX3GSOU EXTENSION 3 GRANTED—
Feb 7, 2005MAILPAPER RECEIVED—
Jan 31, 2005EXT3SOU EXTENSION 3 FILED—
Jan 31, 2005EEXTSOU TEAS EXTENSION RECEIVEDThe applicant requested more time to file a Statement of Use before the Notice of Allowance deadline. Each extension typically adds six months. A limited number of extensions are available for intent-to-use applications not yet in use.
Jul 16, 2004EX2GSOU EXTENSION 2 GRANTED—
Jul 16, 2004EXT2SOU EXTENSION 2 FILED—
Jul 16, 2004EEXTSOU TEAS EXTENSION RECEIVEDThe applicant requested more time to file a Statement of Use before the Notice of Allowance deadline. Each extension typically adds six months. A limited number of extensions are available for intent-to-use applications not yet in use.
Feb 19, 2004EX1GSOU EXTENSION 1 GRANTED—
Feb 3, 2004EXT1SOU EXTENSION 1 FILED—
Feb 3, 2004EEXTSOU TEAS EXTENSION RECEIVEDThe applicant requested more time to file a Statement of Use before the Notice of Allowance deadline. Each extension typically adds six months. A limited number of extensions are available for intent-to-use applications not yet in use.
Aug 19, 2003NOAMNOA MAILED - SOU REQUIRED FROM APPLICANTA Notice of Allowance means your intent-to-use application cleared examination and opposition but is not registered yet. You must file a Statement of Use showing the mark in commerce, or request an extension, before the deadline — usually six months from the notice date.
May 27, 2003PUBOPUBLISHED FOR OPPOSITIONYour mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance.
May 7, 2003NPUBNOTICE OF PUBLICATION—
Apr 8, 2003CNSAAPPROVED FOR PUB - PRINCIPAL REGISTER—
Mar 27, 2003DOCKASSIGNED TO EXAMINER—

Frequently asked questions

Related guidance